DE102019128842A1 - Verfahren, Vorrichtung und Markersubstanz-Kit zur multiparametrischen Röntgenfluoreszenz-Bildgebung - Google Patents
Verfahren, Vorrichtung und Markersubstanz-Kit zur multiparametrischen Röntgenfluoreszenz-Bildgebung Download PDFInfo
- Publication number
- DE102019128842A1 DE102019128842A1 DE102019128842.8A DE102019128842A DE102019128842A1 DE 102019128842 A1 DE102019128842 A1 DE 102019128842A1 DE 102019128842 A DE102019128842 A DE 102019128842A DE 102019128842 A1 DE102019128842 A1 DE 102019128842A1
- Authority
- DE
- Germany
- Prior art keywords
- sample
- ray fluorescence
- marker
- marker substance
- molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003550 marker Substances 0.000 title claims abstract description 238
- 239000000126 substance Substances 0.000 title claims abstract description 226
- 238000000034 method Methods 0.000 title claims abstract description 60
- 238000002213 X-ray fluorescence microscopy Methods 0.000 title claims abstract description 26
- 238000004876 x-ray fluorescence Methods 0.000 claims abstract description 134
- 239000013543 active substance Substances 0.000 claims abstract description 49
- 238000009826 distribution Methods 0.000 claims abstract description 49
- 239000003446 ligand Substances 0.000 claims abstract description 35
- 238000001514 detection method Methods 0.000 claims abstract description 26
- 238000003384 imaging method Methods 0.000 claims abstract description 20
- 230000005855 radiation Effects 0.000 claims abstract description 12
- 230000003993 interaction Effects 0.000 claims abstract description 10
- 239000002105 nanoparticle Substances 0.000 claims description 148
- 239000002245 particle Substances 0.000 claims description 39
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 28
- 229910052737 gold Inorganic materials 0.000 claims description 28
- 239000010931 gold Substances 0.000 claims description 28
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 25
- 229910052697 platinum Inorganic materials 0.000 claims description 13
- 239000011258 core-shell material Substances 0.000 claims description 10
- 238000011156 evaluation Methods 0.000 claims description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 8
- 239000002872 contrast media Substances 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 230000005284 excitation Effects 0.000 claims description 8
- 229910052740 iodine Inorganic materials 0.000 claims description 8
- 239000011630 iodine Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 7
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 6
- 229910052788 barium Inorganic materials 0.000 claims description 5
- 229910052741 iridium Inorganic materials 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 229910052797 bismuth Inorganic materials 0.000 claims description 4
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 4
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 4
- 230000010399 physical interaction Effects 0.000 claims description 4
- 229910052792 caesium Inorganic materials 0.000 claims description 2
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 claims description 2
- 239000002502 liposome Substances 0.000 claims description 2
- 239000007769 metal material Substances 0.000 claims description 2
- 230000001678 irradiating effect Effects 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 114
- 239000003814 drug Substances 0.000 description 61
- 229940079593 drug Drugs 0.000 description 59
- 238000005259 measurement Methods 0.000 description 32
- 238000002083 X-ray spectrum Methods 0.000 description 17
- 230000008901 benefit Effects 0.000 description 16
- 210000002865 immune cell Anatomy 0.000 description 15
- 238000001228 spectrum Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 238000002600 positron emission tomography Methods 0.000 description 11
- 239000000700 radioactive tracer Substances 0.000 description 11
- 230000008878 coupling Effects 0.000 description 9
- 238000010168 coupling process Methods 0.000 description 9
- 238000005859 coupling reaction Methods 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 7
- 238000002603 single-photon emission computed tomography Methods 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000009102 absorption Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000002591 computed tomography Methods 0.000 description 5
- 238000007306 functionalization reaction Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000002123 temporal effect Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229940039231 contrast media Drugs 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 208000011231 Crohn disease Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000090 biomarker Substances 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- RIWAPWDHHMWTRA-UHFFFAOYSA-N 1,2,3-triiodobenzene Chemical group IC1=CC=CC(I)=C1I RIWAPWDHHMWTRA-UHFFFAOYSA-N 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000002925 chemical effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- -1 concentrations Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000009513 drug distribution Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000011158 quantitative evaluation Methods 0.000 description 2
- 238000012883 sequential measurement Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000002247 constant time method Methods 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 238000011982 device technology Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 239000003168 generic drug Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
- G01N23/22—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by measuring secondary emission from the material
- G01N23/223—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by measuring secondary emission from the material by irradiating the sample with X-rays or gamma-rays and by measuring X-ray fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
- G01N23/22—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by measuring secondary emission from the material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
- G01N23/22—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by measuring secondary emission from the material
- G01N23/2202—Preparing specimens therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2223/00—Investigating materials by wave or particle radiation
- G01N2223/07—Investigating materials by wave or particle radiation secondary emission
- G01N2223/076—X-ray fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2223/00—Investigating materials by wave or particle radiation
- G01N2223/40—Imaging
- G01N2223/401—Imaging image processing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2223/00—Investigating materials by wave or particle radiation
- G01N2223/60—Specific applications or type of materials
- G01N2223/612—Specific applications or type of materials biological material
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Nanotechnology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Nuclear Medicine (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102019128842.8A DE102019128842A1 (de) | 2019-10-25 | 2019-10-25 | Verfahren, Vorrichtung und Markersubstanz-Kit zur multiparametrischen Röntgenfluoreszenz-Bildgebung |
| EP20797446.0A EP4049011A1 (de) | 2019-10-25 | 2020-10-23 | Verfahren, vorrichtung und markersubstanz-kit zur multiparametrischen röntgenfluoreszenz-bildgebung |
| CN202080074754.5A CN114667447B (zh) | 2019-10-25 | 2020-10-23 | 用于多参数x射线荧光成像的方法、设备和标记物质套件 |
| JP2022524594A JP7635224B2 (ja) | 2019-10-25 | 2020-10-23 | マルチパラメトリックｘ線蛍光イメージングのための方法および装置 |
| US17/771,460 US20220370645A1 (en) | 2019-10-25 | 2020-10-23 | Method, device and marker substance kit for multi-parametric x-ray fluorescence imaging |
| PCT/EP2020/079909 WO2021078950A1 (de) | 2019-10-25 | 2020-10-23 | Verfahren, vorrichtung und markersubstanz-kit zur multiparametrischen röntgenfluoreszenz-bildgebung |
| KR1020227017433A KR20220091515A (ko) | 2019-10-25 | 2020-10-23 | 다중-파라미터 x-선 형광 이미징을 위한 방법, 장치 및 마커 물질 키트 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102019128842.8A DE102019128842A1 (de) | 2019-10-25 | 2019-10-25 | Verfahren, Vorrichtung und Markersubstanz-Kit zur multiparametrischen Röntgenfluoreszenz-Bildgebung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE102019128842A1 true DE102019128842A1 (de) | 2021-04-29 |
Family
ID=73020205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE102019128842.8A Withdrawn DE102019128842A1 (de) | 2019-10-25 | 2019-10-25 | Verfahren, Vorrichtung und Markersubstanz-Kit zur multiparametrischen Röntgenfluoreszenz-Bildgebung |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220370645A1 (https=) |
| EP (1) | EP4049011A1 (https=) |
| JP (1) | JP7635224B2 (https=) |
| KR (1) | KR20220091515A (https=) |
| CN (1) | CN114667447B (https=) |
| DE (1) | DE102019128842A1 (https=) |
| WO (1) | WO2021078950A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116577358B (zh) * | 2023-05-18 | 2024-01-23 | 杭州宇称电子技术有限公司 | 基于x射线k-吸收边的书画文物颜料成像方法及其应用 |
| CN118961777B (zh) * | 2024-07-19 | 2025-11-28 | 中国科学院金属研究所 | 一种准原位追踪高温合金微量元素分布的方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120307962A1 (en) * | 2009-12-16 | 2012-12-06 | Georgia Tech Resarch Corporation | Systems and methods for x-ray fluorescence computed tomography imaging with nanoparticles |
| US20160252471A1 (en) * | 2013-08-28 | 2016-09-01 | The Regents Of The University Of California | Nanoparticle assisted scanning focusing x-ray fluorescence imaging and enhanced treatment |
| DE102017003517A1 (de) * | 2017-04-11 | 2018-10-11 | Universität Hamburg | Verfahren und Messvorrichtung zur Röntgenfluoreszenz-Messung |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1603459A1 (en) | 2003-03-07 | 2005-12-14 | Philips Intellectual Property & Standards GmbH | Method and imaging system for imaging the spatial distribution of an x-ray fluorescence marker |
| JP5557266B2 (ja) | 2008-07-17 | 2014-07-23 | 国立大学法人 筑波大学 | 蛍光エックス線検出装置 |
| JP5761102B2 (ja) | 2012-03-29 | 2015-08-12 | コニカミノルタ株式会社 | 高輝度半導体ナノ粒子集積体 |
| FR2989280B1 (fr) | 2012-04-13 | 2017-02-24 | Univ Claude Bernard Lyon | Nanoparticules ultrafines comme agent de contraste multimodal |
| EP3091903B1 (en) * | 2014-01-07 | 2018-10-03 | Jettec AB | X-ray micro imaging |
| CN108469445B (zh) * | 2018-03-29 | 2020-09-01 | 福州大学 | 用于无背景检测血液中癌症抗原含量的基于x射线激发的镧系荧光纳米粒子的试剂盒及制备 |
| JP2019183047A (ja) | 2018-04-13 | 2019-10-24 | Ａｇｃ株式会社 | 蛍光ナノ粒子およびその製造方法 |
-
2019
- 2019-10-25 DE DE102019128842.8A patent/DE102019128842A1/de not_active Withdrawn
-
2020
- 2020-10-23 KR KR1020227017433A patent/KR20220091515A/ko active Pending
- 2020-10-23 JP JP2022524594A patent/JP7635224B2/ja active Active
- 2020-10-23 US US17/771,460 patent/US20220370645A1/en active Pending
- 2020-10-23 CN CN202080074754.5A patent/CN114667447B/zh active Active
- 2020-10-23 EP EP20797446.0A patent/EP4049011A1/de active Pending
- 2020-10-23 WO PCT/EP2020/079909 patent/WO2021078950A1/de not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120307962A1 (en) * | 2009-12-16 | 2012-12-06 | Georgia Tech Resarch Corporation | Systems and methods for x-ray fluorescence computed tomography imaging with nanoparticles |
| US20160252471A1 (en) * | 2013-08-28 | 2016-09-01 | The Regents Of The University Of California | Nanoparticle assisted scanning focusing x-ray fluorescence imaging and enhanced treatment |
| DE102017003517A1 (de) * | 2017-04-11 | 2018-10-11 | Universität Hamburg | Verfahren und Messvorrichtung zur Röntgenfluoreszenz-Messung |
Non-Patent Citations (8)
| Title |
|---|
| CORMODE, David P.; NAHA, Pratap C.; Fayad., Zahi A.: Nanoparticle contrast agents for computed tomography: a focus on micelles. In: Contrast Media & Molecular Imaging, 2014, No. 9, S. 37- 52. * |
| FIEDLER, Haidi D. [u.a.]: Simultaneous nondestructive analysis of palladium, rhodium, platinum, and gold nanoparticles using energy dispersive X-ray fluorescence. In: Analytical Chemistry, Bd. 85, 2013, H. 21, S. 10142-10148. ISSN 1520-6882 (E); 0003-2700 (P). DOI: 10.1021/ac402419r. * |
| GRÜNER, Florian [u.a.]: Localising functionalised gold-nanoparticles in murine spinal cords by X-ray fluorescence imaging and background-reduction through spatial filtering for human-sized objects. In: Scientific Reports, Bd. 8, 2018, Artikelnummer: 16561. ISSN 2045-2322 (E). DOI: 10.1038/s41598-018-34925-3. URL: https://www.nature.com/articles/s41598-018-34925-3.pdf [abgerufen am 11.12.2019]. * |
| HOSSAIN, Mainul; WANG, Chaoming; SU, Ming: Multiplexed biomarker detection using x-ray fluorescence of composition-encoded nanoparticles. In: Applied Physics Letters, Vol. 97, 2010, S. 263704-1-263704-3. * |
| KHRENNIKOV, K. [u.a.]: Tunable all-optical quasimonochromatic Thomson X-ray source in the nonlinear regime. In: PHYSICAL REVIEW LETTERS. 2015, Bd. 114, H. 19, Artikel-Nr. 195003. ISSN 0031-9007 (P); 1079-7114 (E). DOI: 10.1103/PhysRevLett.114.195003. URL: http://umu.diva-portal.org/smash/get/diva2:1093441/FULLTEXT01.pdf [abgerufen am 12.09.2017]. * |
| LI, Yuyang [et al.]: A Library of Potential Nanoparticle Contrast Agents for X-Ray Fluorescence Tomography Bioimaging. In: Contrast Media & Molecular Imaging, Vol. 2018, 2018, Article ID 8174820, S. 1-7. * |
| PELLEGRINO, Teresa [u.a.]: Hydrophobic nanocrystals coated with an amphiphilic polymer shell: A general route to water soluble nanocrystals. In: Nano Letters, Bd. 4, 2004, H. 4, S. 703-707. ISSN 1530-6992 (E); 1530-6984 (P). DOI: 10.1021/nl035172j. URL: https://pubs.acs.org/doi/pdf/10.1021/nl035172j [abgerufen am 11.12.2019]. * |
| ZHANG, Run [u.a.]: X-ray fluorescence imaging of metals and metalloids in biological systems. In: American Journal of Nuclear Medicine and Molecular Imaging, Bd. 8, 2018, H. 3, S. 169-188. ISSN 2160-8407 (E). URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056246/pdf/ajnmmi0008-0169.pdf [abgerufen am 11.12.2019]. * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022553761A (ja) | 2022-12-26 |
| CN114667447A (zh) | 2022-06-24 |
| WO2021078950A1 (de) | 2021-04-29 |
| KR20220091515A (ko) | 2022-06-30 |
| CN114667447B (zh) | 2025-11-18 |
| EP4049011A1 (de) | 2022-08-31 |
| US20220370645A1 (en) | 2022-11-24 |
| JP7635224B2 (ja) | 2025-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3610249B1 (de) | Verfahren und messvorrichtung zur röntgenfluoreszenz-messung | |
| EP2150179B1 (de) | Auswahlverfahren für zwei kontrastmittel zur verwendung in einer dual-energy-ct-untersuchung, kontrastmittelkombination und erzeugung von ct-aufnahmen mit einer kontrastmittelkombination mit unterschiedlichen energiespektren | |
| DE69633782T2 (de) | Vorrichtung undverfahren zum bestimmen der raumkoordinaten von radiomarkiertem gewebe | |
| DE10143131B4 (de) | Verfahren zur Ermittlung von Dichte- und Ordnungszahlverteilungen bei radiographischen Untersuchungsverfahren | |
| DE10151670A1 (de) | Bildgebungsverfahren und Bildgebungsvorrichtung, insbesondere für die Kleintierbildgebung | |
| DE102011053762A1 (de) | System und Verfahren zum Bandpassfiltern für Dualenergie-CT | |
| DE10311628B4 (de) | Bildgebungsverfahren | |
| DE10225932B4 (de) | Bildgebendes Verfahren und Vorrichtung zu dessen Durchführung | |
| DE102009030714A1 (de) | Verfahren zur Absorptionskorrektur von PET-Daten und MR-PET-Anlage | |
| DE10350532A1 (de) | Verfahren und Vorrichtung zur Feststellung von Struktur-, Perfusions- und Funktionsabnormitäten | |
| DE102011053890A1 (de) | Verwendung mehrerer Materialien für die Verbesserung der spektralen Notch-Filterung in der spektralen Bildgebung | |
| WO2007028450A2 (de) | Vorrichtung zur untersuchung von gewebeproben | |
| DE112013002890T5 (de) | Dynamisches Nuklearemissions- und Röntgenbildgebungsgerät und entsprechendes Verfahren | |
| DE102019128842A1 (de) | Verfahren, Vorrichtung und Markersubstanz-Kit zur multiparametrischen Röntgenfluoreszenz-Bildgebung | |
| DE102007036559A1 (de) | Verfahren und eine Vorrichtung zur Detektion und Lokalisierung eines metabolischen Markers | |
| EP3400877A1 (de) | Verfahren zur bildgebung eines untersuchungsbereichs mit erstem kontrastmittel und zweitem kontrastmittel | |
| DE2315525A1 (de) | Verfahren und vorrichtung zur bestimmung der raeumlichen verteilung einer radioaktiven substanz | |
| DE102008041941A1 (de) | Stabilisierung von bildgebenden Verfahren in der medizinischen Diagnostik | |
| US10603001B2 (en) | Energy modulated luminescence tomography | |
| DE102009011801A1 (de) | Verfahren zur Erzeugung eines CT-Bilddatensatzes mit einem bestimmten Röntgenenergiespektrum und CT-System | |
| EP3441005B1 (de) | Analyse von läsionen mit hilfe der multi-energie-ct-bildgebung | |
| DE102012223651A1 (de) | Abbildungsverfahren für ein Resektat und Bilderzeugungsvorrichtung zum Durchführen eines solchen Abbildungsverfahrens | |
| Moss et al. | Use of Photon Scattering Interactions in Diagnosis and Treatment of Disease | |
| DE102007016880A1 (de) | Anordnung zur In-vitro-Bildgebung | |
| EP3378399A1 (de) | Röntgenstreumessvorrichtung und verfahren zur röntgenstreumessung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R012 | Request for examination validly filed | ||
| R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee |